SheMed raises £37m funding round from investors to expand GLP-1 offering and healthcare platform for women

SheMed operates a digital healthcare platform focused on women’s metabolic and hormonal health, combining medical oversight, GLP-1 treatment, data-driven monitoring and continuous support to deliver personalised care outside traditional clinical settings.